Artia Global Partners LP
MIAMI, FL · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$491.8M2026 Q3+ $3.9M options (notional, not included)
Positions51
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.62.7%
What Changed This Quarter?
Top Holdings
INSM
Insmed
13.6%
RVMD
Revolution Medicines
7.7%
ABVX
Abivax S.A.
7.3%
BTSG
BrightSpring Health Services
7.0%
TRVI
Trevi Therapeutics
6.4%
ARGX
Argenx
5.8%
TVTX
Travere Therapeutics
4.7%
ALKS
Alkermes
3.7%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.